A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Valued customer; On this selected Product size, Canada Pharmacy is currently faced with regional restrictions on the export of pharmaceuticals related to the ongoing COVID-19 pandemic. As a result, we have been forced to put a temporary maximum order limit of a 30-day supply on this product. To do our best to support you during this challenging time Canada Pharmacy will be offering the following to customers placing medication orders:
RESTASIS (Cyclosporine) is an ophthalmic medication prescribed to treat certain conditions of the eye. RESTASIS (cyclosporine) treats keratoconjunctivitis sicca, which is when the eye produces fewer tears because of inflammation. During inflammation, the eye is swollen, red, and sometimes itchy and irritated. Inflammation may slow or stop tear production.
RESTASIS increases the production of tears, relieving dry eyes
RESTASIS contains an immunosuppressive agent, cyclosporine, that reduces inflammation. The exact mechanism is not well understood.
Instill one drop of RESTASIS twice daily into each eye.
Separate the administration of RESTASIS by at least 15 minutes from other ophthalmic products.
The vial should be gently inverted several times until the solution becomes a uniform, white, and opaque.
The active ingredient of RESTASIS is cyclosporine 0.05%.
The inactive ingredients are carbomer copolymer type A, castor oil, polysorbate 80, purified water, and sodium hydroxide.
Do not touch the tip of RESTASIS to the eye or other surfaces. Doing so may contaminate the product and lead to infections of the eye.
Remove contact lenses before applying RESTASIS. Lenses should be reinserted at least 15 minutes after applying RESTASIS.
RESTASIS has not shown to increase tear production in patients taking topical anti-inflammatory drugs or those wearing punctal pugs.
The most common adverse effects of RESTASIS include:
RESTASIS eye drops can be bought online with a valid prescription from a doctor.